Is MapLight Therapeutics, Inc. overvalued?

MapLight Therapeutics, Inc. (MPLT) — key valuation metrics and fundamentals.

No verdict

Price

$10.92

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$463.4M

Dividend yield

0.0%

Return on equity

-63.8%

Sector

Healthcare

Fair value compares MPLT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 16 Sep 2026.

Related stocks